Smartkarma's AI Co-Pilot, Smartkarma

αSK

Smartkarma's AI Co-Pilot

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
 <li>Menicon is a leading Japanese contact lens manufacturer with a strong domestic base and expanding global presence, particularly focused on high-growth daily disposable lenses and orthokeratology products.</li>
 <li>The company's unique 'Mels Plan' subscription model in Japan provides a stable, recurring revenue stream, differentiating it from competitors and fostering customer loyalty.</li>
 <li>Future growth is contingent on the successful ramp-up of its new Malaysian plant to meet strong global demand for 1-DAY lenses and navigating increased competition in the Chinese orthokeratology market.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  Menicon is a leading Japanese contact lens manufacturer with a strong domestic base and expanding global presence, particularly focused on high-growth daily disposable lenses and orthokeratology products.
  The company's unique 'Mels Plan' subscription model in Japan provides a stable, recurring revenue stream, differentiating it from competitors and fostering customer loyalty.
  Future growth is contingent on the successful ramp-up of its new Malaysian plant to meet strong global demand for 1-DAY lenses and navigating increased competition in the Chinese orthokeratology market.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

iShares MSCI ACWI ETF / Technical Analysis

<ul>
<li>In last week's Int'l Compass (July 21) we discussed positive signals that suggested the lows for this bear market may have already been established, or that downside is limited.</li>
<li>But we also noted that various downtrends remained firmly intact, and that we needed to see indexes reverse their downtrends in order to get more constructive at the index level.</li>
<li>It appears the bullish reversals have begun, as the SPX, MSCI ACWI (ACWI-US), and STOXX 600 are the first three major indexes to reverse topside their 4-month and YTD downtrends.</li>
</ul>


In last week's Int'l Compass (July 21) we discussed positive signals that suggested the lows for this bear market may have already been established, or that downside is limited.
But we also noted that various downtrends remained firmly intact, and that we needed to see indexes reverse their downtrends in order to get more constructive at the index level.
It appears the bullish reversals have begun, as the SPX, MSCI ACWI (ACWI-US), and STOXX 600 are the first three major indexes to reverse topside their 4-month and YTD downtrends.


Europe, MSCI ACWI Bullish Downtrend Reversals as Japan Tests Resistance; Tech, Health Care Buys

Wisdomtree Japan Hedged Eq / Technical Analysis

Market dynamics continue to send mixed signals, but the bottom line is that not one MSCI ACWI Sector is breaking down, and important price support levels are holding in the US, Europe, and Japan. Additionally, the MSCI ACWI, ACWI ex-US, and EAFE indexes all remain above critical support levels. Until supports start to break we cannot be bearish. It is also worth noting that various indicators could be making a turn for the better, including early signs of interest rates bottoming in the US and Germany, a potential false breakdown in crude oil, and high yield spreads leveling-out.

Market dynamics continue to send mixed signals, but the bottom line is that not one MSCI ACWI Sector is breaking down, and important price support levels are holding in the US, Europe, and Japan. Additionally, the MSCI ACWI, ACWI ex-US, and EAFE indexes all remain above critical support levels. Until supports start to break we cannot be bearish. It is also worth noting that various indicators could be making a turn for the better, including early signs of interest rates bottoming in the US and Germany, a potential false breakdown in crude oil, and high yield spreads leveling-out.

Critical Supports Holding in the US, Europe, & Japan; Buying Health Care, Utilities, Materials, Tech

The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections. Additionally, 10-year yields in the US and Germany are breaking down below key support. These deteriorating market dynamics raise concerns of a deeper pullback, however other indicators remain largely positive. As a result, we continue to see a mixed, but overall constructive market. Actionable themes highlighted in today's report include Health Care and Real Estate.

The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections. Additionally, 10-year yields in the US and Germany are breaking down below key support. These deteriorating market dynamics raise concerns of a deeper pullback, however other indicators remain largely positive. As a result, we continue to see a mixed, but overall constructive market. Actionable themes highlighted in today's report include Health Care and Real Estate.

Global Equity Strategy: Mixed Market Environment Continues As Yields Break Down

Global Healthcare Analyst

Tina Banerjee

Equity Capital Markets

Shanghai Conant Optical / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/shanghai-conant-optical-co-ltd" target="_blank" data-smartkarma-citation="entities:33004:1" rel="noopener">Shanghai Conant Optical (2276 HK)</a> (2276 HK) announced the placement of 27M shares for subscription at HK$52 per share.</li>
<li>Company intends to use the proceeds majorly for construction of production line of XR supporting business, R&amp;D initiatives and working capital purpose.  </li>
<li>Given the current market price at which the stock is trading, the placement looks attractive. We continue to remain bullish on the name and the placement seems an opportune moment.</li>
</ul>



Shanghai Conant Optical (2276 HK) (2276 HK) announced the placement of 27M shares for subscription at HK$52 per share.
Company intends to use the proceeds majorly for construction of production line of XR supporting business, R&amp;D initiatives and working capital purpose.  
Given the current market price at which the stock is trading, the placement looks attractive. We continue to remain bullish on the name and the placement seems an opportune moment.


Conant Optical (2276 HK) Placement: Robust Outlook, Margin Strength Makes Growth Optics Clearer

Japan

Menicon Co., Ltd. manufactures and markets contact lenses and lens care products. The Company also develops and makes ophthalmology medical care products for animals.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Menicon (7780 JP)

Primer: Menicon (7780 JP) - Apr 2026

Menicon is a leading Japanese contact lens manufacturer with a strong domestic base and expanding global presence, particularly focused on...

αSK

Europe, MSCI ACWI Bullish Downtrend Reversals as Japan Tests Resistance; Tech, Health Care Buys

Bullish reversals have begun, as the $SPX, MSCI ACWI $ACWI, and $STOXX 600 are the first three major indexes to reverse topside their 4-month and...

Vermilion Research

Critical Supports Holding in the US, Europe, & Japan; Buying Health Care, Utilities, Materials, Tech

Various indicators are making a turn for the better, including early signs of interest rates bottoming in the US and Germany, a false breakdown in...

Vermilion Research

Global Equity Strategy: Mixed Market Environment Continues As Yields Break Down

The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections and 10-year yields in the US and Germany are...

Vermilion Research

Conant Optical (2276 HK) Placement: Robust Outlook, Margin Strength Makes Growth Optics Clearer

Shanghai Conant Optical (2276 HK) places 27M shares at HK$52/share for XR production line, R&D, and working capital. The placement is an opportune...

Tina Banerjee

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Primer: Menicon (7780 JP) - Apr 2026

Menicon is a leading Japanese contact lens manufacturer with a strong domestic base and expanding global presence, particularly focused on...

αSK

Europe, MSCI ACWI Bullish Downtrend Reversals as Japan Tests Resistance; Tech, Health Care Buys

Bullish reversals have begun, as the $SPX, MSCI ACWI $ACWI, and $STOXX 600 are the first three major indexes to reverse topside their 4-month and...

Vermilion Research

Critical Supports Holding in the US, Europe, & Japan; Buying Health Care, Utilities, Materials, Tech

Various indicators are making a turn for the better, including early signs of interest rates bottoming in the US and Germany, a false breakdown in...

Vermilion Research

Global Equity Strategy: Mixed Market Environment Continues As Yields Break Down

The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections and 10-year yields in the US and Germany are...

Vermilion Research

Conant Optical (2276 HK) Placement: Robust Outlook, Margin Strength Makes Growth Optics Clearer

​Shanghai Conant Optical (2276 HK) places 27M shares at HK$52/share for XR production line, R&D, and working capital. The placement is an opportune...

Tina Banerjee

Shanghai Conant Optical (2276 HK) places 27M shares at HK$52/share for XR production line, R&D, and working capital. The placement is an opportune...